# Senior Advisor Subject Matter Expert (SME) with Patient Advocacy Expertise for the NINDS Ultra-rare Gene-based Therapy (URGenT) Network

Notice e58e04d968d94c408f28ef95e2d6048f (solicitation 7571PS27Q00015) from HEALTH AND HUMAN SERVICES, DEPARTMENT OF, OMAS STRATEGIC BUYING CENTER - PROFESSIONAL SERVICES, posted 2026-10-27, responses due 2026-11-02T18:00:00.000Z. Status: open.

| Field | Value |
| --- | --- |
| Notice ID | e58e04d968d94c408f28ef95e2d6048f |
| Solicitation number | 7571PS27Q00015 |
| Type | Combined Synopsis/Solicitation |
| Agency | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Sub-tier | OFFICE OF THE ASSISTANT SECRETARY FOR FINANCIAL RESOURCES (ASFR) |
| Office | OMAS STRATEGIC BUYING CENTER - PROFESSIONAL SERVICES |
| Posted | 2026-10-27T22:19:51.000Z |
| Response deadline (UTC) | 2026-11-02T18:00:00.000Z |
| Set-aside | Small Business Set Aside - Total |
| NAICS | 541690 |
| PSC | R499 |
| Place of performance | Rockville, MD, USA |
| Award | - |

## Description

COMBINED SYNOPSIS / SOLICITATION (COMPETITIVE) Title: Senior Advisor Subject Matter Expert (SME) with Patient Advocacy Expertise for the NINDS Ultra-rare Gene-based Therapy (URGenT) Network (i) This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with RFO Part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued. The solicitation number is 7571PS27Q00015 issued as a Request for Quote for a Senior Advisor to act as a Subject Matter Expert (SME) with Patient Advocacy Expertise The Government reserves the right to make one award, multiple awards, or no awards as a result of this solicitation. This acquisition is set-aside for small business concerns. This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. (ii) This requirement is for the following services: NINDS is seeking to procure a highly experienced executive-level, drug discovery and development Senior Advisor 2 Subject Matter Expert (SME) with experience in the area of Patient Advocacy to provide feedback to the NINDS program leadership and technical guidance on drug discovery and development projects within the URGenT portfolio. The Contractor will serve as a member of the URGenT External Counselor Board (ECB), which provides strategic guidance on URGenT projects and on occasion other NINDS drug discovery and development programs. (iii) Description of requirement: The NIH is seeking to procure a highly experienced executive-level Senior Advisor 2, drug discovery and development subject matter expert with experience in the area Patient Advocacy to provide feedback to the NIH program leadership and technical guidance on drug discovery and development projects as members of URGenT ECB to NINDS Leadership programs. The Contractor shall provide this support while serving for URGenT ECB. The ECB may meet up to 8 times/year for approximately one - two hours and on an ad-hoc basis for milestone and/or introductory calls of URGenT projects via teleconference. ECB members may be requested to attend one on site visit to the NIH campus yearly for ECB meetings. See Attachment #1 - Statement of Work (SOW) for more information. (iv) The Government anticipates award of a Fixed Price purchase order for this acquisition, and the anticipated base period of performance is: Base: 11/06/2026 – 11/05/2027 Option Year 1: 11/06/2027 – 11/05/2028 Option Year 2: 11/06/2028 – 11/05/2029 (v) The provisions a FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at this address: https://www.acquisition.gov/far-overhaul https://www.hhs.gov/contract-policies-regulations/hhsar-overhaul (End of provision) The following FAR provisions are required by FAR 12.2025(a), and incorporated by reference: FAR 52.212-1 (Nov 2025) (RFO Deviation), Instructions to Offerors-Commercial Products and Commercial Services. The following FAR provisions are required as applicable to this requirement and incorporated by reference: See Attachment 2 for (Table # 12-2) under FAR 12.205 (a)(3). The following HHSAR provisions are applicable to this requirement and incorporated by reference (available upon request): HHSAR 352.239.78 – Information and Communication Technology Accessibility Notice (FEB 2024) (Deviation) (vi) The clauses at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: https://www.acquisition.gov/far-overhaul https://www.hhs.gov/contract-policies-regulations/hhsar-overhaul (End of clause) The following FAR clauses are required by FAR 12.205(b)(1) for all solicitations and incorporated by reference: FAR 52.212-4 (Nov 2025) (RFO Deviation), Terms and Conditions—Commercial Products and Commercial Services. The following FAR clauses are required as applicable to this requirement and incorporated by reference: See Attachment 3: Table# 12-3. FAR 52.232-39, Unenforceability of Unauthorized Obligations (Jun 2013). The following HHSAR clauses are applicable to this requirement and incorporated by reference: HHSAR 352.204-71, Information and Information System Security (FEB 2024) (Deviation). HSHAR 352-204-73 – Contractor Personnel Security and Agency Access (FEB 2024) (Deviation). HHSAR 352-239-79 – Information and Communication Technology Accessibility (Feb 2024) (Deviation). FAR/HHSAR PROVISIONS/CLAUSES – FULL TEXT-ADDITIONAL TERMS AND CONDITIONS The following provisions/clauses and additional terms and conditions apply to this acquisition and are provided in FULL TEXT: HHSAR 352-237-75 Key Personnel (Oct 2026) (RFO Deviation) - Key personnel specified in this contract are essential to work performance under the contract. The Contractor must obtain the written consent of the Contracting Officer prior to diverting, replacing, or announcing any key p

## Sources

- View on SAM.gov: https://sam.gov/opp/e58e04d968d94c408f28ef95e2d6048f/view
- Data as of 2026-11-14. Source: https://sam.gov/data-services/Contract%20Opportunities/datagov

## Cite this

"Senior Advisor Subject Matter Expert (SME) with Patient Advocacy Expertise for the NINDS Ultra-rare Gene-based Therapy (URGenT) Network, SAM.gov contract opportunity e58e04d968d94c408f28ef95e2d6048f." samgovapi.io, https://samgovapi.io/opportunity/e58e04d968d94c408f28ef95e2d6048f, data as of 2026-11-14. Primary record: https://sam.gov/opp/e58e04d968d94c408f28ef95e2d6048f/view

## API and MCP

- REST: GET https://samgovapi.io/api/v1/opportunities/e58e04d968d94c408f28ef95e2d6048f
- MCP tool: get_opportunity

Independent. Not affiliated with, endorsed by or sponsored by GSA, SAM.gov or any U.S. government agency. Registering in SAM.gov is free at sam.gov.

Get a free API key: https://samgovapi.io/sign-up?ref=ai-claudebot